Erbe Medical India Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 7.50 Cr
- Company Age 17 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
About Erbe Medical India
Erbe Medical India Private Limited (EMIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 09 February 2007 and has a history of 17 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Christian Erbe, Marcus Felstead, Rakesh Kundu, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U33119DL2007PTC429896
-
Company No.
062336
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 Feb 2007
-
Date of AGM
06 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Erbe Medical India Private Limited offer?
Erbe Medical India Private Limited offers a wide range of products and services, including Medical Equipment & Accessories, Medical Equipment, Surgical Accessories, Needle Electrodes, Dermatology Equipment, Cryosurgical System, Welding Electrodes, Tungsten Electrodes, Cautery Machine, Surgical Cautery Patient Plate.
Who are the key members and board of directors at Erbe Medical India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Kundu
|
Managing Director | 09-Mar-2016 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Christian Erbe
|
Director | 09-Feb-2007 | Current |
|
Marcus Felstead
|
Director | 07-Oct-2015 | Current |
|
Daniel Zimmermann
|
Director | 20-Jan-2021 | Current |
Financial Performance of Erbe Medical India.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Erbe Medical India?
Unlock access to Erbe Medical India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Erbe Medical India?
Unlock and access historical data on people associated with Erbe Medical India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Erbe Medical India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Erbe Medical India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
